RENOSTEN

chemicals in the form of proprietary crystalline structure for use in manufacture of pharmaceutical preparations and dietary supplements

pharmaceutical preparations, for the prevention and/or treatment of osteoporosis and other bone disorders, for the prevention and/or treatment of hypertension and other cardiovascular disorders, and for the prevention and/or treatment of renal disease; dietary supplements